Chronic obstructive pulmonary disease: moving from symptom relief to mortality reduction

Chronic obstructive pulmonary disease (COPD) has a 3-year mortality rate up to 37%, 2–6 times higher than the general population. We present evidence supporting pharmacological therapies to improve patient life expectancy, focusing on inhaled corticosteroids (ICSs) combined with long-acting bronchod...

Descripción completa

Detalles Bibliográficos
Autores principales: Celi, Alessandro, Latorre, Manuela, Paggiaro, Pierluigi, Pistelli, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127735/
https://www.ncbi.nlm.nih.gov/pubmed/34035887
http://dx.doi.org/10.1177/20406223211014028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127735/
https://www.ncbi.nlm.nih.gov/pubmed/34035887
http://dx.doi.org/10.1177/20406223211014028

Ejemplares similares